What is the recommended prophylaxis for high altitude (HA) sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

High Altitude Sickness Prophylaxis

Acetazolamide 125-250 mg twice daily starting 24 hours before ascent is the recommended first-line prophylaxis for high altitude sickness. 1

Primary Prophylactic Measures

Non-Pharmacological Prevention

  1. Gradual Acclimatization (First-line approach)
    • Ascend slowly at 300-600m/day above 2500m 1, 2
    • Include rest days (one day for every 600-1200m gained) 1
    • Pre-acclimatize by spending at least nine nights at altitudes >2500m within 30 days before ascent if rapid ascent is unavoidable 2
    • Maintain adequate hydration 1
    • Avoid overexertion 1

Pharmacological Prophylaxis

For General High Altitude Sickness Prevention:

  • Acetazolamide:
    • Dosage: 125-250 mg twice daily 1
    • Timing: Start 24 hours before ascent 1
    • Duration: Continue during ascent and for 2-3 days at maximum altitude 3
    • Mechanism: Carbonic anhydrase inhibitor that increases ventilation and improves oxygenation 2
    • Particularly indicated when:
      • Rapid ascent is unavoidable (>300m/day) 2
      • Traveling to altitudes >3350m (11,000 feet) by air 3
      • Previous history of altitude sickness 4

For Those with History of High Altitude Pulmonary Edema (HAPE):

  • Nifedipine:
    • Dosage: 20 mg extended-release every 8 hours 1, 2
    • Timing: Start one day before ascent 2
    • Duration: Continue during ascent and for 3-4 days after reaching final altitude 1
    • Mechanism: Vasodilator that decreases pulmonary artery pressure 2, 5

Contraindications and Special Considerations

Acetazolamide Contraindications:

  • Kidney stones
  • Sulfa allergy
  • Severe hepatic or renal disease
  • Adrenocortical insufficiency
  • Hyperchloremic acidosis
  • Sickle cell disease
  • Aplastic anemia 1

Monitoring Requirements:

  • Serum electrolytes
  • Renal function
  • Acid-base status 1

Population-Specific Considerations:

  • Women: Higher risk of acute mountain sickness; consider iron supplementation 1
  • Cardiovascular patients: Consult physician before high altitude travel; acetazolamide may reduce risk of subendocardial ischemia 1
  • Hypertensive patients: Well-controlled hypertensive patients may reach very high altitudes (>4000m) with adequate therapy; uncontrolled/severe hypertensive patients should avoid high altitude exposure 6

Recognition and Management of Altitude Illness

Symptoms to Monitor:

  • Mild to Moderate AMS: Headache, insomnia, anorexia, nausea, dizziness 7, 4
  • Severe AMS: Vomiting, dyspnea, muscle weakness, peripheral edema 4
  • HAPE: Incapacitating fatigue, chest tightness, dyspnea, dry cough progressing to pink frothy sputum 5
  • HACE: Severe headache unresponsive to acetaminophen, ataxia, mental deterioration 5

Treatment:

  • Immediate descent is the primary treatment for severe altitude illness 1
  • Supplemental oxygen to maintain saturation >90% 1
  • Dexamethasone for cerebral edema (not recommended for prophylaxis) 7, 4
  • Nifedipine for treatment of HAPE 7, 5

Common Pitfalls and Caveats

  • Don't rely solely on medications without proper acclimatization
  • Don't ignore early symptoms of altitude sickness
  • Don't continue ascent if symptoms develop
  • Don't combine acetazolamide with other diuretics due to increased risk of dehydration and electrolyte imbalances 1
  • Limit caffeine intake when taking acetazolamide to avoid enhanced side effects 1

References

Guideline

Acetazolamide Guideline Summary

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Prevention and therapy of altitude sickness].

Therapeutische Umschau. Revue therapeutique, 1993

Research

A trek to the top: a review of acute mountain sickness.

The Journal of the American Osteopathic Association, 1995

Research

[Mountaineering and altitude sickness].

Therapeutische Umschau. Revue therapeutique, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Travelling to high altitude areas--acute high altitude sickness].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.